You also have it backwards because it already reliably makes society better for you. Take the case of Biogen employee Michael Bawduniak, who spent seven years documenting covert payments that steered doctors toward Biogen’s multiple‑sclerosis drugs illegally. When the United States Department of Justice settled the case for $900 million in 2022, Bawduniak received roughly $266 million, or about 30% of the federal proceeds, under the False Claims Act. It's a very similar mechanism, and anyone you may know who suffers from multiple sclerosis has likely had their treatment options materially improved thanks to Bawduniak's actions. But those kinds of actions only happen when you have the right mechanisms in place, to reward people who do the right thing.